Ondine Biomedical’s Steriwave Adopted by UK Hospital
Company Announcements

Ondine Biomedical’s Steriwave Adopted by UK Hospital

Ondine Biomedical, Inc. (GB:OBI) has released an update.

Ondine Biomedical Inc.’s Steriwave nasal decolonization technology will be employed by Leeds Teaching Hospitals NHS Trust to combat infections in patients undergoing skull base surgery. Steriwave offers a quick, one-time antimicrobial treatment that reduces the risk of post-operative infections and the need for antibiotics, aligning with the UK’s plan to combat antimicrobial resistance. This innovation has already been adopted by other UK hospitals for surgical site infection prevention and is part of a growing effort to improve patient outcomes and reduce healthcare costs.

For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskOndine Biomedical Secures C$16.2 Million for US Trials
TipRanks UK Auto-Generated NewsdeskOndine Biomedical Inc. Launches £8.5 Million Fundraise
TipRanks UK Auto-Generated NewsdeskOndine Biomedical Inc. Secures Interim Funding Boost
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App